Novanta Inc
NASDAQ:NOVT
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
144.33
186.2
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Novanta Inc
Novanta Inc
Cash Equivalents
Novanta Inc
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Novanta Inc
NASDAQ:NOVT
|
Cash Equivalents
$92.7m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
9%
|
CAGR 10-Years
6%
|
|
|
Teledyne Technologies Inc
NYSE:TDY
|
Cash Equivalents
$561m
|
CAGR 3-Years
1%
|
CAGR 5-Years
34%
|
CAGR 10-Years
16%
|
|
|
Keysight Technologies Inc
NYSE:KEYS
|
Cash Equivalents
$1.8B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
|
|
Trimble Inc
NASDAQ:TRMB
|
Cash Equivalents
$1B
|
CAGR 3-Years
26%
|
CAGR 5-Years
41%
|
CAGR 10-Years
22%
|
|
|
Zebra Technologies Corp
NASDAQ:ZBRA
|
Cash Equivalents
$676m
|
CAGR 3-Years
30%
|
CAGR 5-Years
83%
|
CAGR 10-Years
27%
|
|
|
Cognex Corp
NASDAQ:CGNX
|
Cash Equivalents
$662k
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
1%
|
|
Novanta Inc
Glance View
Novanta Inc. is a thriving technology company operating at the intersection of precision optics, advanced motion control, and industrial automation. Founded in 1978, the company has transformed itself over the decades, evolving from a niche player in the photonics industry into a robust provider of critical components and solutions that drive the growth of various sectors, including healthcare, life sciences, and automation. With a keen focus on innovation, Novanta develops products like high-performance lasers, vision systems, and motion control technologies that enable their customers to enhance productivity and precision in their applications. Their commitment to quality and performance has established Novanta as a trusted partner for many leading global brands, ensuring sustainable growth and strong industry positioning. Investor confidence in Novanta is bolstered by its strategic emphasis on high-growth markets and a strong track record of profitability. The company's dedication to research and development has fostered a culture of continuous improvement, allowing it to adapt swiftly to changing market demands and technological advancements. As the demand for automation and high-precision solutions continues to surge globally, Novanta is well-positioned to capitalize on this trend. With a careful balance of organic growth and strategic acquisitions, Novanta is not just growing; it is building a portfolio that promises long-term value creation. For investors seeking exposure to the advancing technological landscape, Novanta Inc. represents a compelling opportunity, combining innovative prowess with a strong financial foundation and a bright growth trajectory in its core markets.
See Also
What is Novanta Inc's Cash Equivalents?
Cash Equivalents
92.7m
USD
Based on the financial report for Sep 27, 2024, Novanta Inc's Cash Equivalents amounts to 92.7m USD.
What is Novanta Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
6%
Over the last year, the Cash Equivalents growth was 22%. The average annual Cash Equivalents growth rates for Novanta Inc have been -3% over the past three years , 9% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
